| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Newamsterdam Pharma Co N.V. (NAMS) has 11 insiders with recent SEC Form 4 filings, including 3 buys and 1 sell. NAMS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 3.03M | $83.80M | - | |
| CEO | 378.9K | $10.48M | - | |
| Other | 99.0K | $2.74M | - | |
| CFO | 58.4K | $1.62M | - | |
| Other | 24.4K | $673.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 20, 2024 | Davidson Michael H.65 | Chief Executive Officer | Buy | 5,000 | $17.26 | $86,308.50 | +2.5% | -7.4% | +4.2% | |
| Mar 26, 2024 | Kastelein Johannes Jacob Pieter54 | Chief Scientific Officer | Sale+OE | 190,476 | $21.50 | $4,095,234.00 | -100% | -13.6% | -0.7% | |
| Mar 26, 2024 | Topper James N89 | Director | Buy | 8,429 | $21.50 | $181,223.50 | +0.3% | -13.6% | -0.7% | |
| Feb 13, 2024 | Lange Louis G | Director | Buy | 5,000 | $19.00 | $95,000.00 | +25.2% | +1.1% | -3.1% |